En Rich Financial Partners LLC Exact Sciences Corp Transaction History
En Rich Financial Partners LLC
- $273 Billion
- Q2 2024
A detailed history of En Rich Financial Partners LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, En Rich Financial Partners LLC holds 328 shares of EXAS stock, worth $21,785. This represents 0.01% of its overall portfolio holdings.
Number of Shares
328
Previous 908
63.88%
Holding current value
$21,785
Previous $62.7 Million
77.88%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
610Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.21 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.1 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$982 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$801 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$545 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.8B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...